A University of Melbourne & Texas Medical Center backed Australian Precision Medicine software company trading since 2012. Aim: Fast-Track finding the right antidepressant with genetics. CNSDose - our US$140 cutting edge RCT evidence backed blood-brain-barrier pharmacogenetic powered report boosts antidepressant remission rates. Start a conversation with your doctor... A large fully independent randomized controlled trial to confirm clinical utility in complex depression started recruiting in 2021. If positive, CNSDose may well be declared the gold standard in the segment globally. Watch this space.
View Top Employees from CNSDoseWebsite | https://incitehealth.com.au/en-au/products/cns-dose-test/ |
Employees | 6 (5 on RocketReach) |
Founded | 2012 |
Technologies |
HTML,
Google Analytics,
Google Tag Manager
+10 more
(view full list)
|
Industry | Medical and Diagnostic Laboratories, Mental health, Health Care, Biotechnology |
Looking for a particular CNSDose employee's phone or email?
Ajeet Singh is the Founder and Director of CNSDose.
5 people are employed at CNSDose.
CNSDose is based in Melbourne, Victoria.